Allergan Recalls Eye Treatments Due to Particles

Aug 26, 2015

Allergan is voluntarily recalling certain lots of eye-treatment ointments sold in the U.S. amid customer complaints of a small black particle breaking off the cap and contaminating the product.

Reported Adverse Events include 12 reports of foreign body in the eye as well as a few reports of eye irritation, discomfort and pain.

The recall includes specific lots of its REFRESH Lacri-Lube for dry eye, REFRESH PM, FML 0.1% topical anti-inflammatory agent for ophthalmic use, and Blephamide 10%/0.2%.

Read the FDA recall notice

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments